{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"0"}],"title":"Experienced at least a 2 point improvement in neuropathy between baseline and Week 10"},{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"}],"title":"Did not experience at least a 2 point improvement in neuropathy between baseline and Week 10"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"description":"Neuropathy will be subject reported using an 11-point scale from 0-no neuropathy to 10-worst possible neuropathy. The outcome will be measured as a binary variable indicating whether or not a subject experienced at least a 2-point improvement in neuropathy between the baseline score and the score obtained at Week 10 +/- 1 week.","groups":[{"description":"Acupuncture: 12 acupuncture sessions over 10 weeks","id":"OG000","title":"Acupuncture"},{"description":"Standard of Care CIPN management: Investigator directed standard of care management of CIPN","id":"OG001","title":"Standard of Care"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"The analysis population are those that met the evaluable population criteria, which was enrolled subjects who have complete baseline and Week 10 neuropathy scores.","reportingStatus":"POSTED","timeFrame":"Approximately 10 weeks, from baseline measure to 10 week (+/- 1 week) measure.","title":"Change of Neuropathy in Actively Treated Multiple Myeloma Subjects Diagnosed With Chemotherapy-induced Peripheral Neuropathy Who Received Acupuncture vs Standard of Care Management.","type":"PRIMARY","unitOfMeasure":"Participants"}